Piricyclamide TLGCMNGTERCLGLP
| Internal ID | 88cd6586-7be7-4cc1-9f8b-6d99e810fcf5 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | 3-[(1R,4S,10S,16S,19S,22S,28S,31S,34S,40S,43S,46S)-34-(2-amino-2-oxoethyl)-46-[3-(diaminomethylideneamino)propyl]-19,40-bis[(1R)-1-hydroxyethyl]-4,10,22-tris(2-methylpropyl)-31-(2-methylsulfanylethyl)-2,5,8,11,17,20,23,26,29,32,35,38,41,44,47-pentadecaoxo-50,51-dithia-3,6,9,12,18,21,24,27,30,33,36,39,42,45,48-pentadecazatricyclo[26.20.4.012,16]dopentacontan-43-yl]propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C63H105N19O20S3/c1-29(2)20-37-51(91)68-24-45(86)71-40(22-31(5)6)62(102)82-18-11-13-43(82)59(99)81-50(33(8)84)61(101)78-38(21-30(3)4)52(92)69-25-46(87)72-41-27-104-105-28-42(58(98)76-37)79-54(94)34(12-10-17-67-63(65)66)73-55(95)35(14-15-48(89)90)75-60(100)49(32(7)83)80-47(88)26-70-53(93)39(23-44(64)85)77-56(96)36(16-19-103-9)74-57(41)97/h29-43,49-50,83-84H,10-28H2,1-9H3,(H2,64,85)(H,68,91)(H,69,92)(H,70,93)(H,71,86)(H,72,87)(H,73,95)(H,74,97)(H,75,100)(H,76,98)(H,77,96)(H,78,101)(H,79,94)(H,80,88)(H,81,99)(H,89,90)(H4,65,66,67)/t32-,33-,34+,35+,36+,37+,38+,39+,40+,41-,42+,43+,49+,50+/m1/s1 |
| InChI Key | CCULVWMSKMCNLG-UUKVWBFRSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C63H105N19O20S3 |
| Molecular Weight | 1544.80 g/mol |
| Exact Mass | 1543.69454034 g/mol |
| Topological Polar Surface Area (TPSA) | 689.00 Ų |
| XlogP | -3.70 |
| Atomic LogP (AlogP) | -7.49 |
| H-Bond Acceptor | 23 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 20 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5733 | 57.33% |
| Caco-2 | - | 0.8601 | 86.01% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Lysosomes | 0.4875 | 48.75% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8413 | 84.13% |
| OATP1B3 inhibitior | + | 0.9329 | 93.29% |
| MATE1 inhibitior | - | 0.8200 | 82.00% |
| OCT2 inhibitior | - | 0.7000 | 70.00% |
| BSEP inhibitior | + | 0.9625 | 96.25% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8774 | 87.74% |
| CYP3A4 substrate | + | 0.7143 | 71.43% |
| CYP2C9 substrate | - | 0.6072 | 60.72% |
| CYP2D6 substrate | - | 0.8425 | 84.25% |
| CYP3A4 inhibition | - | 0.9843 | 98.43% |
| CYP2C9 inhibition | - | 0.8288 | 82.88% |
| CYP2C19 inhibition | - | 0.7977 | 79.77% |
| CYP2D6 inhibition | - | 0.8931 | 89.31% |
| CYP1A2 inhibition | - | 0.8223 | 82.23% |
| CYP2C8 inhibition | + | 0.7460 | 74.60% |
| CYP inhibitory promiscuity | - | 0.9955 | 99.55% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.5912 | 59.12% |
| Eye corrosion | - | 0.9810 | 98.10% |
| Eye irritation | - | 0.8956 | 89.56% |
| Skin irritation | - | 0.7550 | 75.50% |
| Skin corrosion | - | 0.9117 | 91.17% |
| Ames mutagenesis | - | 0.5900 | 59.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6541 | 65.41% |
| Micronuclear | + | 0.7400 | 74.00% |
| Hepatotoxicity | - | 0.5195 | 51.95% |
| skin sensitisation | - | 0.8259 | 82.59% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.8333 | 83.33% |
| Mitochondrial toxicity | + | 0.8000 | 80.00% |
| Nephrotoxicity | + | 0.6061 | 60.61% |
| Acute Oral Toxicity (c) | III | 0.5242 | 52.42% |
| Estrogen receptor binding | + | 0.6217 | 62.17% |
| Androgen receptor binding | + | 0.6792 | 67.92% |
| Thyroid receptor binding | + | 0.6096 | 60.96% |
| Glucocorticoid receptor binding | + | 0.7051 | 70.51% |
| Aromatase binding | + | 0.7750 | 77.50% |
| PPAR gamma | + | 0.7447 | 74.47% |
| Honey bee toxicity | - | 0.7151 | 71.51% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6400 | 64.00% |
| Fish aquatic toxicity | - | 0.4618 | 46.18% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.86% | 83.82% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.75% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.68% | 96.09% |
| CHEMBL4071 | P08311 | Cathepsin G | 99.38% | 94.64% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 99.30% | 85.14% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.55% | 91.11% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 97.24% | 96.11% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 97.21% | 94.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.44% | 94.45% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.07% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.03% | 90.71% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 94.80% | 97.05% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 94.77% | 95.50% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 93.52% | 94.45% |
| CHEMBL4447 | Q9Y337 | Kallikrein 5 | 93.47% | 87.50% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 92.85% | 97.25% |
| CHEMBL1801 | P00747 | Plasminogen | 91.85% | 92.44% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 91.58% | 97.64% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.95% | 96.90% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 90.41% | 95.89% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 90.22% | 95.00% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 89.66% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 89.58% | 95.56% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 88.69% | 95.93% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 88.23% | 93.03% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 87.80% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 87.00% | 94.66% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 86.74% | 90.08% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 86.66% | 96.47% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 86.24% | 82.38% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 85.93% | 97.14% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 85.20% | 96.25% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 85.08% | 87.16% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 85.04% | 99.17% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 84.74% | 96.00% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 84.62% | 92.88% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 84.25% | 95.56% |
| CHEMBL228 | P31645 | Serotonin transporter | 83.69% | 95.51% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 83.52% | 80.71% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 83.51% | 91.03% |
| CHEMBL2068 | P29317 | Ephrin type-A receptor 2 | 83.45% | 97.49% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 83.30% | 99.18% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.04% | 100.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 82.99% | 98.59% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 82.85% | 99.23% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.64% | 90.24% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 81.38% | 93.56% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 81.25% | 100.00% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 81.24% | 98.00% |
| CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 80.93% | 85.83% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 80.80% | 96.67% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 80.61% | 96.31% |
| CHEMBL2189110 | Q15910 | Histone-lysine N-methyltransferase EZH2 | 80.28% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684890 |
| LOTUS | LTS0236229 |
| wikiData | Q104203010 |